OGT has announced the expansion of its SureSeq portfolio with a complete library preparation solution for hybridization-based target capture in NGS.
Oxford Gene Technology (OGT) has announced the expansion of its SureSeq portfolio with a complete library preparation solution for hybridization-based target capture in next-generation sequencing (NGS).
Through the expansion, which includes an updated and refined library preparation workflow, as well as a new, ready-to-use hybridization and wash buffer, OGT has made its MGS coverage and expertise more accessible. The SureSeq NGS portfolio features targeted panels, library preparation kits, and a software package.
“With this expansion of our SureSeq portfolio, we have further broken down the barriers for hybridization in NGS, making it quicker, easier, and more flexible, while also delivering enormous benefits to researchers in terms of data quality,” said John Anson, CEO of OGT in a June 13, 2019 press release. “OGT has a reputation for quality and expertise and together with Sysmex we see NGS as a key future technology. As part of a large, global IVD company, we are exploring many exciting possibilities, and it is our aim that future development plans in this area will be transformative for our customers.”
Source: OGT
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.